Evidence map›Paper›PMID 32312587›Full record

ArticleJournal of Ayurveda and integrative medicine

Vasant Kusmakar Ras, an ayurvedic herbo-mineral formulation prevents the development of diabetic retinopathy in rats.

Sanjay Motilal Tamoli, Kuldip Raj Kohli, Aakruti Arun Kaikini, Suraj Abhimanyu Muke, Afroj Abdulgani Shaikh, Sadhana Sathaye

Open access · goldAbstract read
In one paragraph

Article in Journal of Ayurveda and integrative medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Sanjay Motilal TamoliR. A. Podar Ayurved Medical College, Dr. Annie Besant Road, Worli, Mumbai, Maharashtra, 400018, India.
Kuldip Raj KohliDirectorate of AYUSH, Govt. of Maharashtra, St.George Hospital, Mumbai, Maharashtra, 400001, India.
Aakruti Arun KaikiniInstitute of Chemical Technology, Department of Pharmaceutical Sciences and Technology, Pharmacology Research Lab-II, A-252, Nathalal Parkeh Marg, Matunga (East), Mumbai, 400019, India.
Suraj Abhimanyu MukeInstitute of Chemical Technology, Department of Pharmaceutical Sciences and Technology, Pharmacology Research Lab-II, A-252, Nathalal Parkeh Marg, Matunga (East), Mumbai, 400019, India.
Afroj Abdulgani ShaikhInstitute of Chemical Technology, Department of Pharmaceutical Sciences and Technology, Pharmacology Research Lab-II, A-252, Nathalal Parkeh Marg, Matunga (East), Mumbai, 400019, India.
Sadhana SathayeInstitute of Chemical Technology, Department of Pharmaceutical Sciences and Technology, Pharmacology Research Lab-II, A-252, Nathalal Parkeh Marg, Matunga (East), Mumbai, 400019, India. Electronic address: sadhanasathaye@hotmail.com.
Institute of Chemical Technology · INPodar Ayurved Medical College · INSt. George Hospital · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiabetic retinopathy is a slow progressing complication of diabetes mellitus with multifactorial aetiology affecting approximately 80% of diabetics worldwide. Chronic hyperglycemic milieu of Diabetes induces biochemical changes which contribute to the pathogenesis of Diabetic retinopathy.

objectiveThe present study examined the protective effect of Vasant Kusumakar Ras, an Ayurvedic herbo-mineral formulation, in diabetic retinopathy. MATERIALS AND

methodsDiabetes was induced in rats by intraperitoneal injection of streptozotocin (45 mg/kg). Rats were kept without any treatment for period of three weeks for induction of Diabetic retinopathy followed by treatment with Vasant Kusumakar Ras (11.25 mg/kg, p.o) for further 5 weeks. Fasting blood glucose levels, lipid profile and HbA1c were determined. Eye tissue homogenates were subjected to biochemical analysis to determine the levels of oxidative stress parameters (superoxide dismutase, catalase, reduced glutathione, lipid peroxidation), vascular endothelial growth factor and aldose reductase activity. Histopathological analysis of retinal tissue was conducted using Hematoxylin and Eosin staining.

resultsVasant Kusumakar Ras treatment restored serum lipid profile which was altered in diabetic rats. Treatment with Vasant Kusumakar Ras significantly ameliorated the oxidative stress in eye tissue resulting in decreased lipid peroxidation and increase in endogenous antioxidant levels. Levels of aldose reductase and vascular endothelial growth factor in eye tissue were significantly decreased in Vasant Kusumakar Ras treated rats. Hematoxylin and Eosin staining indicated that the Vasant Kusumakar Ras treatment significantly restored the normal architecture of the retinal tissue.

conclusionVasant Kusumakar Ras exhibits protective effect and prevents the development of Diabetic retinopathy through its effects on multiple biochemical pathways implicated in pathogenesis of Diabetic retinopathy.

Indexed as

Aldose reductaseComplementary medicineDiabetic retinopathyOxidative stressVasant Kusumakar RasVascular endothelial growth factor

Identifiers

PMID32312587
PMCPMC7527844
OpenAlexW3016960761

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.